Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Evaluation of the Ischemia-modified Albumin Levels in the Patients With Sudden Sensorineural Hearing Loss

NCT03706183 is registered in ClinicalTrials.gov with Yuzuncu Yil University as lead sponsor.

NCT NCT03706183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03706183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Evaluation of the Ischemia-modified Albumin Levels in the Patients With Sudden Sensorineural Hearing Loss
Lead sponsor
Yuzuncu Yil University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2018
Completion date
January 31, 2019
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia, sudden hearing loss